Many other questions must arise, but preliminary answers to these four are
SEVERAL hundreds of cases have been recorded of auricular fibrillation in which normal rhythm has been restored, and we can accept it as demonstrated that quinidine can bring about this change of mechanism in a large proportion of all cases. Our knowledge of the pharmacology of quinidine has been greatly extended by the recent work of Lewis and his colleagues [1] , but our knowledge of the therapeutics is small, probably because of lack of ability to ascertain the causes of auricular fibrillation in patients.
Like all powerful drugs quinidine can bring about effects that are unpleasant or even dangerous, and so, necessarily, we should learn in what cases the conversion can be effected without producing such results. The advantages to be gained might conceivably be so great that the risk of unpleasant symptoms is not a serious deterrent to giving the drug, but in digitalis we have so successful a method of treating the effects of auricular fibrillation that we must seriously consider in what cases a successful quinidine result surpasses the effect of digitalis treatment in therapeutic value. To maintain the normal rhythm it may prove in some cases to be necessary to continue the administration for a long time or even indefinitely. This may produce greater comfort or efficiency than the continuous administration of digitalis.
If quinidine treatment is to find a place in general therapeutics, answers to the two following questions must be obtained: (a) desirable before the necessary amount of material will be collected on which sound therapeutics can be based.
The effect of quinidine on disturbances of the mechanism of the heartbeat other than auricular fibrillation and flutter will, I have no doubt, be referred to by other speakers, but my experience with them has been too small to justify any reference from me. Many interesting electro-cardiographic phenomena have been observed as a result of quinidine treatment, but this is probably not a suitable occasion for their discussion in detail.
I shall first describe four cases in which the administration of quinidine resulted in dangerous symptoms, or in symptoms so distressing that the administration had to be stopped before any beneficial effects were produced.
(1) Aimiong the earlier cases in which I tried quinidine was that of a woman, aged 54, with mitral stenosis and regurgitation, who was readmitted in June, 1921, after being under observation and treatment for a year with auricular fibrillation. When first seen in July, 1920, she had auricular flutter, and this had changed to fibrillation as the result of digitalis treatment. No history of rheumnatic disease was obtained. The heart was greatly enlarged both to right and left, and the apex was in the sixth space, 5 in. fromn the mid-line. Under digitalis treatment she was capable of only very light work in the house. She was put on quinidine sulphate 5 gr. at 9 a.m. and 7.30 p.m., and reverted in twenty-four hours to flutter with an auricular rate of 196. After eight days her pulse-rate, which had continued between 80 and 90, suddenly rose to 200, and the patient felt faint. Probably a 1: 1 response occurred. The treatment was stopped, digitalis was recommenced and fibrillation returned.
(2) A woman, aged 31, with a history of rheumatic fever at 8 years of age and a "weak heart" since, and with mitral stenosis, had auriculat fibrillation with a ventricular rate of only 50-65, and severe heart failure while at complete rest in bed. Presumably some lesion of the auriculo-ventricular conducting structures was present. On quinidine sulphate, 5 gr. three times a day, flutter resulted after five days, with an auricular rate of 186 and a ventricular rate of 93. The dose was raised to 7' gr. three times a day, and six days later, when the auricular rate was 225, with a response of 2: 1 and 4: 1, a Stokes-Adams attack occurred. The patient was being electrocardiographed at the time, and a tracing was obtained showing a ventricular standstill while the auricular activity continued. Auricular fibrillation returned on stopping the quinidine, and the patient died a year later with malignant endocarditis and tricuspid and mitral stenosis.
(3) A woman, aged 58, with mitral regurgitation and auricular fibrillation, probably of eighteen months' duration, had no history of rheumatism, and had evidence of arterial and renal disease. She had a ventricular rate on admission of 180, and the heart was enlarged to the right and left, with the apex in the fifth space 5' in. from the mid-line. The response to digitalis treatment was good, but at a ventricular rate of 90 numerous premature beats occurred. After four doses of 15 gr. of quinidine sulphate at six-hourly intervals, normal mechanism was restored, but the patient experienced much precordial discomfort and nausea. The quinidine was stopped, aind fibrillation returned a day later with relief from the subjective distress.
After the experience of these cases, I selected with care, avoiding all cases with evidence of much damage to cardiac structures, such as great enlargement, heart block, or severe valvular disease. Similar conclusions have already been recorded in the literatuTe.
abdoiminal pain with dyspn(ea, and orthopnoea, and numerous rMles at the bases of tlle lungs. The apex beat was in the fifth space 5 ) in. from the mid-line. The response to digitalis was good. Quinidine sulphate 5 gr. three times a day had no effect, and after four days it was raised to 7. gr. three times a day. On this dose the ventricular rate rose steadily, and on the fifth day, after 175 gr. in all, she complained of headache, vomited, and the temperature rose to 100°F. Next day there was a rash on the abdomein, lower chest, above the back of the elbows, and above the knees on the anterior aspect of the thighs. It consisted of small rose-red papules, raised in the centre and fading into the surrounding skin at the margins. They varied in size from one-twentieth to one-fifth of an inch in diameter, and were in places confluent. Next day the eruption had a morbilliform appearance, and had spread to the back in the lumbar region, on to the upper chest, neck and lower part of face. The arms were affected more on the extensor than on the flexor surfaces. It did not spread below the knees or on to the hands. A few of the lesions were plirpuric. The quinidine was stopped on the first appearance of the rash, which commenced to fade on the third day, but did not entirely disappear till the seventh day.
In the following cases there was little evidence of extensive permanent changes in the cardiac structures and the conversion to normal rhythm resulted without any discomfort to the patient.
(5) A mani, aged 39, was; admiitted in July, 1921, with auricular fibrillation of probably five months' duration. He had syphilitic aortitis. No valvular lesion was discoverable, but the apex beat was in the sixth space 51-in. from the mid-line. Three mlonths previously when first seen he had severe heart failure at rest in bed, but he had responded well to digitalis and had been put on antisyphilitic treatment. The Wassermann reaction became negative, but he had much precordial distress and palpitations, anid there were numerous ventricular extrasystoles. Quinidine sulphate 5 gr. three timles a day was increased to 10 gr. three times a day after six days, and four days later, after 180 gr., norinal rhythun was restored. Three days later the dosage was reduced to 5 gr. three times a day, and this was continued for three months while he was attending as an out-patient. A year and a half later the rhythm is still normal, and he states that he feels fit to return to his work as a stevedore. There are still occasional ventricular extrasystoles.
I would suggest that in this case the treatment of the cause of the heart disease was an important factor in the success.
(6) A man, aged 26, was admitted in July, 1921, with dyspncea, aedema and auriculal fibrillation which had probably been present for six weeks only. No clear evidence of -alvular disease was obtained and no evidence of any infection other than nmalaria five y-ears before with recurrent attacks up to three months before admission. He responded well to digitalis and there was but little enlargement of the heart. Quinidine sulphate 5 gr. three timies a day was increased to 10 gr. three times a day after twentyfour hours and on the third day, after 55 gr., normal rhythm was restored. The dose was reduced to 5 gr. three times a day two days later, and this was continued for ten days more. The normal rhythm has continued ever since, and he is now working as a labourer, but has occasional precordial distress.
In this case it appears probable that the cause of the auricular fibrillation, whatever it was, had ceased to be active when the patient came under observation.
The auricular fibrillation associated with exophthalmic goitre or other thyro-toxic conditions is of peculiar interest, since the thyro-toxic condition can be treated, and the next three cases are examples of the action of quinidine in different stages of thyro-toxic activity. Australia without relief and the signs of heart failure were pronounced unless tlhe patient remlainied at complete rest in bed. He responded wvell to digitalis at the National Heart Hospital under the care of Dr. Strickland Goodall. A further thyroidectomy was performed by Mr. T. P. Dunhill, in October, 1922, at St. Bartholornew's Hospital, with great improvement in the thyro-toxic symptomiis, but the auricular fibrillation was still present three weeks later. He was, put on quinidine sulphate 5 gr. three times a day, and after four doses the rhythni becaiiie normal. There was no evidence of valvular disease, and the apex beat was in the fourth space 41 in. from the mid-iine. The quinidine was continued in diminishing dosage for a further ten days.
The rhythm is still normal and the patient is steadily increasing his activities.
The removal of the toxic thyroid gland probably removed the cause of thie fibrillation, and the quinidine was of value in disturbing a mechanism that tends to be stable when once developed.
(8) A woman, aged 45, had exophthalmic goitre seven years ago. After various medical treatmelnts the general thyro-toxic condition gradually subsided, but without improvement in the palpitations, oedema and shortness of breath. It is probable that auricular fibrillation had been present for some years. On admission in July, 1922, she had cedemna of the legs, back, and bases of the lungs, and the apex beat was in the fifth space 41 in. from the mid-line. The response to digitalis was good and she was discharged a month later. In October, 1922, she was readmitted to try the effect of quinidine, and it was found that the thyro-toxic symptoms were rather more pronounced than in the summer. After six doses of quinidine sulphate 72 gr. three tinmes a day, the rhythm becamiie normal. The quinidine was gradually reduced and discontinued four weeks later, and when the patient was discharged the apex beat was in the fourth space 31 in. from the mlid-line. While at home she developed a bad cough and auricular fibrillation returned. On readmission in February, 1923, a great increase in the thyro-toxic symiptoms was found to be present, and a partial thyroidectomy was performed on February 22. As she was still fibrillating on March 1, quinidine sulphate 5 gr. three timiies a day was coiniiienced and normal rhythm restored after four doses. She is still on quinidine, and a further thyroidectomy mlay be necessary before all thyro-toxic symptomns disappear and before a stable normal rhythm is obtained.
(9) A woman, aged 46, with large multiple cysts of the thyroid gland of many years' duration, had severe heart failure and auriciilar fibrillation for four weeks. There were thyro-toxic symptoms and the basal metabolic rate was from + 35 per cent. to + 50 per cent. The response to digitalis was good, but the auriculo-ventricular rhythm that resulted from quinidine was unstable, nodal rhythm, auricular extrasystoles and ventricular extrasystoles interfering with the regularity. During a bad attack of quinsy with purpura the thyro-toxic symptoms increased and fibrillation returned in spite of the continued quinidine administration. The quinidine was stopped, and after the subsidence of the acute infection its administration was recommenced and normal rhythm was again established. This persisted through the strain of tonsillectomy and the removal of all her teeth, which were very septic, and is still present two months later. She declines to have tne thyroid gland operated upon and continues to take quinidine 5 gr. three times a day.
These two cases suggest that so long as the cause of the auricular fibrillation remains active, the normal rhythm resulting from quinidine treatment will not be stable, and in the next case this suggestion is supported by the result of treatment in a patient suffering from rheumatic infection of the heart.
(10) A woman, aged 26, with mnitral stenosis and auricular fibrillation gave a history of rheumatic fever four years previously, and of a probable onset of the fibrillation two months previously. There was slight edema of the ankles, severe dyspnoea on exertion, palpitations on exertion and frequently also when at rest. The apex beat was in the fifth space 3I in. from the muid-line. The response to digitalis was good. Quinidine sulphate 5 gr. three times a day caused a return to norual rhythm after seven doses, with cessation of the palpitations and precordial distress that had persisted on digitalis, but the dyspncea was still severe. After thirteen days the dose was reduced to 2 gr. three times a day, and she was discharged on this amount. A month later an attempt was made to relieve the dyspncea by adding tincture of digitalis 5 minims, and later 10 minims, three timies a day, but this was without effect on the symptoms and did not disturb the rhythmn. Three months after leaving hospital she had a bad cold and fibrillation returned for a few days, and a month later pains in the knees, pains over the precordium and attacks of palpitation occurred with a return of auricular fibrillation. The quinidine was stopped and sodiullm salicylate and digitalis were commenced. When the attack, probably one of rheumatic infection, had subsided, quinidine again restored normal rhythm. During the last nine months she has continued to take quinidine 5 gr. three times a day, but has fibrillated for a few days on three definite occasions. On one of these she had much worry in connexion with' the death of her mother, on another she had tried to do some heavy work, and on the third she had a bad cold.
It seems probable that the rheumatic infection is continuously or intermittently active and that the quinidine is just sufficient to prevent fibrillation except during a relapse, when another infection is present, when worry or mental strain occur, or with physical strain. It is difficult to decide that she has a raised efficiency when the rhythm is normal, but she is certainly far more comfortable and contented.
I have seen one case of thyro-toxic auricular fibrillation in which normal rhythm was restored a few days after partial thyroidectomy, without other interference, and have heard of several others; and I have seen cases in which auricular fibrillation occurred only for a few hours after thyroidectomy during the stage when excessive excitement is seen. These cases suggest that the auricular fibrillation is due to an active toxic action, and that normal rhythm may result simply from the cessation of this toxic action. The difficulty in obtaining a stable normal rhythm with quinidine in active toxic cases, and the stability obtained after partial thyroidectomy, indicate clearly that in this type of case in order to obtain a stable normal rhythm the thyro-toxic factor must be treated.
In the other types of cases the indications of a similar active agent are not so complete, but the accumulation of more evidence might well decide in favour of a similar state of affairs in them also. The stability of the syphilitic case in5 which anti-syphilitic treatment was given supports this view. The stability in the case in which no definite valvular lesion could be found, and in which the only known infection was malaria, may well be due to the cessation of the causal factor, whatever it was, before the patient came under observation.
The instability of the rheumatic case when quinidine treatment was continued for nine months is suggestive of a constantly or intermittently active factor tending to produce fibrillation. This idea is fully in keeping with the theory derived from the clinical study of these cases, that the rheumatic infection continues for years, causing gradually increasing stenosis of the mitral valve and death, often without well defined attacks of acute rheumatic infection. In this case it is of interest to note the additional factors present during the relapses into auricular fibrillation, namely worry and mental strain, physical strain, and infection of the upper respiratory tract. Unfortunately we have no successful method of treating the rheumatic infection of the heart.
In addition to active agents, toxic and infectious, it is probable that auricular fibrillation can result from permanent structural changes in the heart, in which case a stable normal rhythm after cessation of the quinidine treatment would be unlikely. I would, therefore, conclude that (1) Quinidine treatment will result in a stable normal rhythm if the cause of the auricular fibrillation can be successfully treated or has ceased to be active.
(2) Cases in which there are extensive structural changes in the heart, as evidenced by heart block, severe valvular disease or great enlargement, are not suitable for quinidine treatment, especially if the response to digitalis is not good. In such cases unpleasant and even' dangerous disturbances may result.
(3) In some cases at least, the comfort and efficiency of the patient are greater when a normal rhythm results from quinidine treatment, than when digitalis treatment alone is used.
(4) In the cases in which the results are satisfactory larger doses than 10 gr. of quinidine sulphate at intervals of six hours are not necessary, nor smaller initial doses than 5 gr. three times a day.
(5) If necessary to maintain normal rhythm quinidine may be continued to be administered indefinitely, and it is probably advisable in all cases to continue it for some weeks after normal rhythm has resulted, though in gradually decreasing doses. Professor Fraser has brought out very many clinical points with regard to the treatment of auricular disease with quinidine. I think that the purpose of this discussion will be better fulfilled if I leave this aspect alone, and speak only of the toxicology of the drug, and outline especially the effect upon the cardiac musculature.
Before entering upon this, I must mention in passing certain symptoms, not peculiar to patients who have cardiac disease, but common to all who are under quinidine therapy.
The first is the sudden collapse, with unconsciousness and failure of respiration, which occurs after a small amount of the drug has been taken. This idiosyncrasy, which is very alarming, is fortunately not common and is tested by giving a small dose of the drug before treatment. The unpleasant symptoms of quinidine poisoning, such as headache, nausea, diarrhcea, and vomiting, which also occur, are not unduly common during quinidine administration, but must be expected to appear in certain cases; the possibility of their occurrence must always be borne in mind.
With regard to the effects which are produced in the cardiac musculature when quinidine is administered. The information, which has been obtained by experiments upon animals, where doses comparable to those employed clinically have been used, has been fully borne out by clinicalfindings; and it can be safely assumed that similar changes are produced in the human cardiac musculature. A study of these changes enables us to understand more clearly the cause of the restoration of the normal rhythm and of its failure; the untoward events which occur during quinidine administration and how to guard against poisoning the heart to a dangerous degree. In short, quinidine lengthens the refractory
